paroxysmal nocturnal hemoglobinuria (PNH) | Page 27 | Aplastic Anemia & MDS International Foundation

paroxysmal nocturnal hemoglobinuria (PNH)

Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena

Author(s): 
Röth A, Hock C, Konik A, Christoph S, Dührsen U
Primary Author: 
Röth A
Journal Title: 
Int J Hematol.
Original Publication Date: 
May 2011

The terminal complement inhibitor

Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux

Author(s): 
Cheng KL, Brody J, Warshall CE, Sloand EM, Allen SL
Primary Author: 
Cheng KL
Journal Title: 
Leuk Res.
Original Publication Date: 
Apr 2010

No abstract available.

Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Author(s): 
Santarone S, Bacigalupo A, Risitano AM, Tagliaferri E, Di Bartolomeo E, Iori AP, Rambaldi A, Angelucci E, Spagnoli A, Papineschi F, Tamiazzo S, Di Nicola M, Di Bartolomeo P.
Primary Author: 
Santarone S
Journal Title: 
Haematologica
Original Publication Date: 
Dec 2009

BACKGROUND:

Paroxysmal nocturnal hemoglobinuria is an acquired clonal disorder of the

Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.

Author(s): 
Helley D, de Latour RP, Porcher R, Rodrigues CA, Galy-Fauroux I, Matheron J, Duval A, Schved JF, Fischer AM, Socié G; French Society of Hematology.
Primary Author: 
Helley D
Journal Title: 
Haematologica
Original Publication Date: 
Apr 2010

BACKGROUND: